medline.ch Onkologie Urologische Tumoren

	Uncertainty-aware hybrid model for reliable navigation guidance in prostate biopsy. Med Phys Soormally C, Beitone C, Troccaz J, Voros S. PMID: 42928638 [PubMed - indexed for MEDLINE]
	Molecular and Immune Features of Metastatic Prostate Cancer in Hispanic and Non-Hispanic American Men. Cancer Rep (Hoboken) Recio-Boiles A, Deshmukh SK, Everly CJ, Wu S, Estrada-Mendizabal RJ, Heath E, McKay RR, Miranti C, Batai K, Lee BR, Chipollini J. PMID: 42928456 [PubMed - indexed for MEDLINE]
	Real-World Safety and Effectiveness of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer: Final Analysis of the RAPIT Study. Target Oncol Huang CY, Huang CP, Huang YY, Huang SK, Lu K, Meng E, Huang SP, Lee MY, Hung SC, Chen F, Pang ST. PMID: 42928397 [PubMed - as supplied by publisher]
	Chromophobe renal cell carcinoma: addressing the translational gap toward precision oncology for advanced disease. J Transl Med Lei X, Dong R, Yin L, Wu Z, Wang L, He M. PMID: 42928313 [PubMed - indexed for MEDLINE]
	Comparative diagnostic accuracy of PSMA-PET versus conventional imaging for Initial T/N/M staging of intermediate- to high-risk prostate cancer: a patient-level paired bivariate meta-analysis. BMC Cancer Wu H, Zhang W, Yang L, Yan X, Song P, Dong Q. PMID: 42928137 [PubMed - indexed for MEDLINE]
	Pembrolizumab plus lenvatinib with belzutifan or quavonlimab as first-line therapy for advanced renal-cell carcinoma: randomized open-label phase 3 LITESPARK-012 study. Ann Oncol Rini BI, Choueiri TK, Voss MH, Burotto M, Oldenburg J, Gurney HP, Ferguson TR, Hammers H, Albiges L, Ürün Y, Romero Diaz RI, Özgüro, Weber PY, Verzoni E, Porta C, Drakaki A, Guo J, Matsubara N, Chen A, Burgents JE, Rodriguez-Lopez KG, Powles TB. PMID: 42927856 [PubMed - as supplied by publisher]
	Final prespecified analysis of the phase 3 LITESPARK-011 study: belzutifan plus lenvatinib versus cabozantinib for advanced renal cell carcinoma after anti-PD-(L)1 therapy. Ann Oncol Heng DYC, Schmidinger M, McDermott R, Park SH, Burotto M, Ciccarese C, Verzoni E, Suárez C, Eto M, Cutuli HJ, Porta C, Kopp RM, Rottey S, de Velasco G, Valderrama BP, Azad AA, De Giorgi U, Pavic M, Tomczak P, Figlin R, Westgeest HM, Guida A, Necchi A, Schutz FA, Suelmann BBM, Haanen JB, Lin J, Perini RF, Vickery D, Motzer RJ, LITESPARK-011 Investigators. PMID: 42927855 [PubMed - as supplied by publisher]
	THE DOUBLE-EDGED SWORD OF ANDROGEN SIGNALING FOR SELECTIVE RADIOSENSITIZATION OF PROSTATE CANCER CELLS. Trans Am Clin Climatol Assoc Deweese TL, Coulter JB, Yegnasubramanian S. PMID: 42927289 [PubMed - indexed for MEDLINE]
	Prospective Clinical Evidence on Artificial Intelligence-Enabled Augmented and Mixed Reality in Robot-Assisted Prostate and Kidney Cancer Surgery: A Systematic Review. Cureus Harrison G. PMID: 42927213 [PubMed]
	Value of multiparametric MRI in predicting postoperative upgrading of prostate cancer with biopsy Gleason Grade Groups 3â€‰+â€‰3 and 3â€‰+â€‰4. BJR Open Zhang J, Zhang X, Bai X, Chen L, Guo E, Wu Y, Zhang G, Jin Z, Sun H. PMID: 42927141 [PubMed]
	Introducing higher harmonic generation microscopy for renal tumour pathology: a perspective on clinical translation. Biophys Rev Duijn M, Spies S, de Haan LT, de Bruin DM, Lange MM, Savci CD, van Delden OM, Groot ML, Zondervan PJ. PMID: 42927108 [PubMed]
	Fumarate Hydratase-Deficient Renal Cell Carcinoma in a Solitary Kidney: Diagnostic Pitfalls and Onco-Nephrology Constraints in an Older Adult With Chronic Kidney Disease. Cureus Sanka S, Mudupula Vemula SS, Kulkarni A, Koduru U, Hrinczenko B. PMID: 42927048 [PubMed]
	Peripheral and selective venous liquid biopsy profiling in localized prostate cancer: A pilot feasibility study. J Liq Biopsy Ricotta R, Trifirò G, Andreolli EM, Spinapolice EG, Tagliabue E, Camerota TC. PMID: 42927017 [PubMed]
	Detection of extraprostatic extension of prostate cancer by transfer learning AI models versus radiologists on biparametric and multiparametric MRI. Res Sq Tong A, Daniels A, Ginocchio L, Smereka P, Dutt T, Umapathy L, Nayan M, Chandarana H, Johnson P. PMID: 42926655 [PubMed]
	Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial. Nat Med Necchi A, Mercinelli C, Maiorano BA, Piacentini M, Cigliola A, Iacovelli R, Ciccarese C, Ligato C, Giannatempo P, Rametta A, Gontero P, Soria F, Schuberth-Wagner C, Wischhusen J, Rössler B, Metterlein M, Ries S, Ross T, Amin A, Dreker T, Hermann F, Lemke L, Klar K, Mitina O, Kamova A, Fettes P, Auckenthaler A, Rao S, Leo E, Lichtenegger FS. PMID: 42926233 [PubMed - as supplied by publisher]
	Overview of the genetic pathogenesis of penile cancer. Urol Oncol Kosuru S, Konda S, Broghammer M, Wong TR, Isali I. PMID: 42926155 [PubMed - as supplied by publisher]
	Exposure to per- and polyfluoroalkyl substances and the odds of renal cell carcinoma: a case-control study. Environ Sci Pollut Res Int Ando S, Harada KH, Oshiro Y, Goya M, Lyu Z, Harada Sassa M, Tokuda Y. PMID: 42925465 [PubMed - as supplied by publisher]
	A false sense of hypoxia: Proâ€‘tumorigenicÂ VHLâ€‘HIF2Î± dysregulation in clear cell renal cell carcinoma (Review). Mol Med Rep A Rahman NQA, Khazali AS, Mohtar MA, Syafruddin SE. PMID: 42924582 [PubMed - indexed for MEDLINE]
	Interpreting International Real-World Survival Outcomes After Avelumab First-Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data. Int J Urol Kasahara R, Ueki T. PMID: 42924551 [PubMed - indexed for MEDLINE]
	Xp11.2 Translocation Renal Cell Carcinoma in an Elderly Woman: A Diagnostic Challenge - A Case Report. Case Rep Oncol Inoue N, Fukuta K, Satake N, Atagi Y, Ozaki K, Nakashima T, Nakanishi R, Izaki H, Furukawa J. PMID: 42923944 [PubMed]

Artikel 1 - 20 / 182435

Seite 1 von 9122

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung